B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of monoclonal long-lived B cells which are apparently resistant to normal apoptotic regulation. Since bone marrow stromal cells play an essential role in B lymphopoiesis, we have investigated whether stromal cells influence B-CLL cell survival. Our results indicate that intimate contact with stromal cells reduces B-CLL cell apoptosis and prevents the loss of bcl-2 protein expression. Binding of B-CLL cells to stromal cells requires simultaneous action of beta1 and beta2 integrins. The interaction between B-CLL cells and other cell types seems important for their survival and may represent an important mechanism underlying accumulation of malignant cells in B-CL...
International audienceB-cell non-Hodgkin lymphoma (B-NHL) evolution and treatment are complicated by...
Adhesion molecule expression on acute and chronic lymphoid leukemia cells of B lineage (B-ALL and B-...
B-cell chronic lymphocytic leukaemia (B-CLL) is a clinically heterogeneous disease characterised by ...
The leukemic B lymphocytes from chronic lymphocytic leukemic (CLL) patients have a long survival in ...
The leukemic B lymphocytes from CLL patients have a long survival in vivo although ex vivo, they rap...
The prolonged life span of chronic lymphocytic leukemia (CLL) cells in vivo is assumed to depend on ...
An in vitro model to mimic in vivo conditions was developed using adherent BM Mesenchymal Stromal Ce...
Leukemic cells from Chronic Lymphocytic Leukemia (CLL) patients interact with stromal cells of the s...
B-cell chronic lymphocytic leukemia (CLL), which is the most common lymphoproliferative disorder, di...
International audienceThe systematic localization of chronic lymphocytic leukemia (CLL) B-cells in t...
<p>The peripheral blood of CLL patients contains various cytokines that can protect CLL B-cells from...
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy. High levels of Bcl-2 and IAP family prote...
The microenvironment encompassing a variety of non-malignant cells in close proximity with malignant...
A growing body of evidence suggests that the resistance of CLL cells to apoptosis is partly mediated...
Adhesion molecule expression on acute and chronic lymphoid leukemia cells of B lineage (B-ALL and B-...
International audienceB-cell non-Hodgkin lymphoma (B-NHL) evolution and treatment are complicated by...
Adhesion molecule expression on acute and chronic lymphoid leukemia cells of B lineage (B-ALL and B-...
B-cell chronic lymphocytic leukaemia (B-CLL) is a clinically heterogeneous disease characterised by ...
The leukemic B lymphocytes from chronic lymphocytic leukemic (CLL) patients have a long survival in ...
The leukemic B lymphocytes from CLL patients have a long survival in vivo although ex vivo, they rap...
The prolonged life span of chronic lymphocytic leukemia (CLL) cells in vivo is assumed to depend on ...
An in vitro model to mimic in vivo conditions was developed using adherent BM Mesenchymal Stromal Ce...
Leukemic cells from Chronic Lymphocytic Leukemia (CLL) patients interact with stromal cells of the s...
B-cell chronic lymphocytic leukemia (CLL), which is the most common lymphoproliferative disorder, di...
International audienceThe systematic localization of chronic lymphocytic leukemia (CLL) B-cells in t...
<p>The peripheral blood of CLL patients contains various cytokines that can protect CLL B-cells from...
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy. High levels of Bcl-2 and IAP family prote...
The microenvironment encompassing a variety of non-malignant cells in close proximity with malignant...
A growing body of evidence suggests that the resistance of CLL cells to apoptosis is partly mediated...
Adhesion molecule expression on acute and chronic lymphoid leukemia cells of B lineage (B-ALL and B-...
International audienceB-cell non-Hodgkin lymphoma (B-NHL) evolution and treatment are complicated by...
Adhesion molecule expression on acute and chronic lymphoid leukemia cells of B lineage (B-ALL and B-...
B-cell chronic lymphocytic leukaemia (B-CLL) is a clinically heterogeneous disease characterised by ...